Multicentre study of ceftazidime/avibactam for Gram-negative bacteria infections in critically ill patients-Reference-Cited by-同舟云学术

Multicentre study of ceftazidime/avibactam for Gram-negative bacteria infections in critically ill patients

Published:2022-03 Issue:3 Volume:59 Page:106536
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Balandín Bárbara,Ballesteros Daniel,Pintado Vicente,Soriano-Cuesta Cruz^ORCID,Cid-Tovar Irene^ORCID,Sancho-González Milagros,Pérez-Pedrero María José,Chicot Marta^ORCID,Asensio-Martín María José,Silva José Alberto^ORCID,de Luna Rafael Ruiz^ORCID,Gesso Cristina Martín-Dal,Rodríguez-Serrano Diego Aníbal^ORCID,Martínez-Sagasti Fernando,Royuela Ana^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference23 articles.

1. Risk stratification for multidrug-resistant Gram-negative infections in ICU patients;Burillo;Curr Opin Infect Dis,2019

2. The role of infection models and PK/PD modelling for optimising care of critically ill patients with severe infections;Tängdén;Intensive Care Med,2017

3. Ceftazidime–avibactam: a review in the treatment of serious Gram-negative bacterial infections;Shirley;Drugs,2018

4. Ceftazidime–avibactam versus doripenem for the treatment of complicated urinary tract infections, including acute pyelonephritis: RECAPTURE, a phase 3 randomized trial program;Wagenlehner;Clin Infect Dis,2016

5. Efficacy and safety of ceftazidime–avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: results from a randomized, controlled, double-blind, phase 3 program;Mazuski;Clin Infect Dis,2016

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ceftazidime-Avibactam as a Salvage Treatment for Severely Infected Immunosuppressed Children;Drug Design, Development and Therapy;2024-07

2. Ceftazidime/avibactam versus polymyxin B in carbapenem-resistant Klebsiella pneumoniae infections: a propensity score-matched multicenter real-world study;Infection;2024-06-17

3. Clinical outcomes and risk factors for mortality in recipients with carbapenem-resistant gram-negative bacilli infections after kidney transplantation treated with ceftazidime-avibactam: a retrospective study;Frontiers in Cellular and Infection Microbiology;2024-05-08

4. Yoğun Bakım Ünitelerinde Çoklu İlaca Dirençli Klebsiella pneumoniae, Escherichia coli ve Pseudomonas aeruginosa Suşlarında Seftazidim-Avibactam Direnç Oranlarının Değerlendirilmesi;Flora the Journal of Infectious Diseases and Clinical Microbiology;2024-03-22

5. The Clinical Efficacy of Adding Ceftazidime/Avibactam to Standard Therapy in Treating Infections Caused by Carbapenem-Resistant Klebsiella pneumonia with blaOXA-48-like Genes;Antibiotics;2024-03-16